Adaptation Dose of Enoxaparin in Moderate Renal Failure Patients With Acute Coronary Syndrome

PHASE4CompletedINTERVENTIONAL
Enrollment

67

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

March 31, 2009

Study Completion Date

March 31, 2009

Conditions
Acute Coronary SyndromeRenal Failure
Interventions
DRUG

dose adaptation of Enoxaparin

A same initial dose of 1 mg/kg will be administrated to all patients. According to creatinine clearance, the next doses (every 12 hours subcutaneously) will be adjusted with a 25% dose reduction if creatinine clearance is comprised between 30 and 50 ml/min.

DRUG

normal injection of Enoxaparine

No dose adaptation of Enoxaparine

Trial Locations (9)

25030

CHU Jean MINJOZ, Besançon

31000

Rangueil Hospital, Toulouse

75013

Pitié Salpêtrière Hospital, Paris

75018

CHU Bichat, Paris

75475

Lariboisiére Hospital, Paris

77400

Lagny center Hospital, Lagny-sur-Marne

91100

Sud Francilien Hospital center, Corbeil

92100

Ambroise Paré Hospital, Boulogne

94010

Henri Mondor Hospital, Créteil

All Listed Sponsors
lead

French Cardiology Society

OTHER

NCT00412802 - Adaptation Dose of Enoxaparin in Moderate Renal Failure Patients With Acute Coronary Syndrome | Biotech Hunter | Biotech Hunter